Life Sciences

Researchers identified how chronic kidney disease causes severe muscle loss: phosphate depletion in muscle tissue activates a protein that breaks down muscle fibers. The finding could lead to new treatments for sarcopenia, a costly condition affecting millions of kidney patients and driving disability in aging populations.EN

A new study reveals that common fMRI brain scans show excessive activity during thinking tasks in older adults, but PET scans measuring actual glucose use tell a different story. The finding challenges how researchers and clinicians interpret aging brain function, with implications for dementia screening and cognitive decline diagnostics.EN

A new study reveals that the immune system's capacity to destroy invading bacteria declines with age, a finding with major implications for vaccine design and infection prevention in older populations. The research suggests personalized approaches to protection may be needed across different age groups.EN

Researchers have completed the first comprehensive analysis of LEUTX, a protein essential for early human embryo development. The work could inform treatments for miscarriage and infertility, while raising important questions for the fertility industry and regulators about how such discoveries translate into clinical applications.EN

Researchers have identified genetic variants that dramatically amplify cardiovascular disease risk—but only in smokers. The finding, from a major European study, suggests that genetic screening could help identify which smokers face the highest danger, potentially reshaping how insurers assess risk and how doctors prioritize interventions.EN

Researchers developed a new method to trace how cancer cells mutate and change over time by analyzing their genetic activity one cell at a time. The breakthrough could help doctors predict which tumors will resist treatment and design better therapies tailored to each patient's cancer.EN

Researchers analyzed how different hormone replacement formulations affect cancer-related genes in postmenopausal women. The findings could help doctors and patients make more informed choices about menopause treatment options, potentially reducing health risks while managing symptoms.EN

Researchers have created a detailed cellular map of immune dysfunction in children with colitis, identifying which immune cells go awry in the disease. The findings could guide development of more targeted treatments and help predict which children will respond to existing therapies, potentially reducing trial-and-error prescribing in pediatric gastroenterology.EN

Researchers evaluated how ustekinumab stacks up against TNF-blocking drugs when Crohn's disease patients need to switch biologics. The findings could help gastroenterologists and insurers make treatment decisions for the estimated 3 million Americans living with inflammatory bowel disease.EN

Researchers discovered that B cells can compensate for a missing immune regulator by boosting an alternative signaling pathway. The finding suggests the immune system has built-in redundancies that could inform drug development for autoimmune diseases and cancer immunotherapy.EN

A major randomized trial shows that treating only the cancerous region of the prostate—rather than removing the entire gland—is a viable option for men with localized disease. The finding could reshape treatment standards and reduce side effects, potentially lowering healthcare costs while preserving quality of life for thousands of patients annually.EN

Researchers found that tumor cells in HPV-related throat cancers exist in multiple distinct states and contain diverse viral variants, allowing them to adapt and potentially escape therapy. The discovery could reshape how doctors approach treatment selection and predict which patients risk treatment failure.EN

Researchers have identified a coordinated on/off mechanism in immune cells that spans multiple organs, opening a pathway to tailor immunological treatments to individual patients. The discovery could transform how doctors approach autoimmune diseases and inflammatory conditions by enabling precision therapies tuned to each person's immune profile.EN

Researchers have shown that lipid nanoparticles can successfully deliver therapeutic mRNA that produces VEGFA—a protein that stimulates blood vessel growth—both in the lab and in living organisms. The advance could expand the toolbox for mRNA-based treatments beyond vaccines and cancer therapies, potentially opening markets in regenerative medicine and chronic wound care.EN

Researchers have identified a previously unknown mechanism by which proton pump inhibitors—among the world's most widely prescribed medications—may disrupt the production of acetylcholine, a crucial neurotransmitter. The finding raises questions about long-term safety in millions of patients and could reshape prescribing guidelines and drug development strategies across gastroenterology and neurology.EN

Researchers have pinpointed how a specific microRNA molecule regulates the genes and proteins involved in muscle cell formation. The finding could open new avenues for treating muscle-wasting diseases and regenerative medicine applications, potentially expanding the addressable market for therapeutic interventions.EN

Researchers have created the first comprehensive atlas showing how bacteria translate genetic instructions into proteins and break them down. The findings could accelerate development of new antibiotics and help companies design more efficient biological manufacturing systems.EN

Researchers have discovered that a molecular modification called m6A controls how cells produce a critical protein that affects both cancer development and genomic stability. The finding could open new therapeutic angles for treating blood cancers by targeting this previously underappreciated control mechanism.EN

Researchers have created the first detailed maps showing how genes are turned on and off in different parts of mammalian tissues. The advance could help pharmaceutical companies develop more precise drugs and understand why diseases affect certain tissue types differently.EN

A new study finds that medications for high blood pressure, diabetes, and cholesterol may reduce biological aging markers—potentially extending healthy lifespan. If confirmed, the finding could reshape how insurers, employers, and health systems evaluate the long-term value of these widely-used drugs.EN

Researchers found that a metabolite of disulfiram, a decades-old alcohol addiction medication, kills cancer cells by disrupting how they make proteins. The discovery could open a new route for cancer treatment using an already-approved, inexpensive drug—potentially accelerating development and reducing costs for patients.EN

A new study finds that education levels and geographic relocation patterns significantly influence mortality outcomes, with effects that go beyond what genetic predisposition alone would suggest. The findings could reshape how public health officials and insurers assess population health risks and design interventions targeting vulnerable groups.EN

Researchers discovered that immunity to a virus commonly carried by people—Epstein-Barr—can mistakenly attack a brain protein, potentially triggering multiple sclerosis. The finding opens a path to new diagnostics and preventive treatments for a disease affecting 2.8 million people globally, with major implications for pharmaceutical development and patient screening.EN

Researchers discovered that cells regulate how quickly they break down messenger RNA to adapt rapidly to environmental stress, essentially turning this molecular decay into a memory system. The finding could reshape drug development and help explain why organisms survive unexpected threats—insights with implications for biotech companies developing adaptive therapies and for understanding disease resilience.EN

Researchers analyzing data from 450,000 UK adults found that physical activity behaviors correlate with reduced biological aging—measured through cellular markers—independent of chronological age. The finding could reshape how employers, insurers, and health systems approach workplace wellness and preventive care strategies.EN